Codiak BioSciences, Inc. Net Income
Codiak BioSciences, Inc. reported Net Income of -$19.28 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2022-11-03
- Codiak BioSciences, Inc. net income (loss) attributable to parent for the quarter ending 2022-09-30 was -$19.28M.
- Codiak BioSciences, Inc. net income (loss) attributable to parent for the quarter ending 2022-06-30 was -$6.78M.
- Codiak BioSciences, Inc. net income (loss) attributable to parent for the quarter ending 2022-03-31 was -$8.03M.
- Codiak BioSciences, Inc. net income (loss) attributable to parent for the quarter ending 2021-12-31 was $16.66M.
- Codiak BioSciences, Inc. net income (loss) attributable to parent for fiscal 2021 was -$37.16M.
- Codiak BioSciences, Inc. net income (loss) attributable to parent for fiscal 2020 was -$91.67M.
- Codiak BioSciences, Inc. net income (loss) attributable to parent for fiscal 2019 was -$77.96M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$19.28M 10-Q · filed 2022-11-03 | -$26.05M derived: sum of 2 quarters · filed 2022-11-03 | -$34.08M 10-Q · filed 2022-11-03 | -$17.42M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | -$6.78M 10-Q · filed 2022-11-03 | -$14.80M 10-Q · filed 2022-08-04 | $1.86M derived: sum of 3 quarters · filed 2022-11-03 | -$19.84M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-03-31 | -$8.03M 10-Q · filed 2022-11-03 | $8.63M derived: sum of 2 quarters · filed 2022-11-03 | -$13.07M derived: sum of 3 quarters · filed 2022-11-03 | -$34.88M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | $16.66M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$5.04M derived: sum of 2 quarters · filed 2022-11-03 | -$26.85M derived: sum of 3 quarters · filed 2022-11-03 | -$37.16M 10-K · filed 2022-03-10 |
| 2021-09-30 | -$21.70M 10-Q · filed 2022-11-03 | -$43.51M derived: sum of 2 quarters · filed 2022-11-03 | -$53.82M 10-Q · filed 2022-11-03 | -$71.78M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$21.81M 10-Q · filed 2022-11-03 | -$32.12M 10-Q · filed 2022-08-04 | -$50.07M derived: sum of 3 quarters · filed 2022-11-03 | -$85.37M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-03-31 | -$10.31M 10-Q · filed 2022-11-03 | -$28.27M derived: sum of 2 quarters · filed 2022-11-03 | -$63.56M derived: sum of 3 quarters · filed 2022-11-03 | -$79.47M derived: sum of 4 quarters · filed 2022-11-03 |
| 2020-12-31 | -$17.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$53.25M derived: sum of 2 quarters · filed 2022-03-10 | -$69.16M derived: sum of 3 quarters · filed 2022-03-10 | -$91.67M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$35.29M 10-Q · filed 2021-11-04 | -$51.21M derived: sum of 2 quarters · filed 2021-11-04 | -$73.71M 10-Q · filed 2021-11-04 | -$95.35M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$15.91M 10-Q · filed 2021-08-05 | -$38.41M 10-Q · filed 2021-08-05 | -$60.05M derived: sum of 3 quarters · filed 2021-08-05 | -$80.72M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$22.50M 10-Q · filed 2021-05-06 | -$44.14M derived: sum of 2 quarters · filed 2021-05-06 | -$64.80M derived: sum of 3 quarters · filed 2021-05-06 | |
| 2019-12-31 | -$21.64M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | -$42.30M derived: sum of 2 quarters · filed 2021-03-17 | -$77.96M 10-K · filed 2021-03-17 | |
| 2019-09-30 | -$20.66M 10-Q · filed 2020-11-19 | -$56.32M 10-Q · filed 2020-11-19 |